Mutations in the gene encoding CADM1 are associated with autism spectrum disorder

被引:76
|
作者
Zhiling, Yu [2 ]
Fujita, Eriko [1 ]
Tanabe, Yuko [1 ]
Yamagata, Takanori [2 ]
Momoi, Takashi [1 ]
Momoi, Mariko Y. [2 ]
机构
[1] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Inherited Metabol Disorder, Div Differentiat & Dev, Kodaira, Tokyo 1878502, Japan
[2] Jichi Med Univ, Dept Pediat, Shimotsukeshi, Tochigi 3290498, Japan
关键词
Autism spectrum disorder; Autism; CADM1; SynCAM1; RA175; Neuroligin; Synapse;
D O I
10.1016/j.bbrc.2008.10.107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The unified idea on the molecular pathogenesis of Autism Spectrum Disorder (ASD) is still unknown although mutations in genes encoding neuroligins and SHANK3 have been shown in a small part of the patients. RA175/SynCAM1/CADM1(CADM1), a member of immunoglobilin superfamily, is another synaptic cell adhesion molecule. To clarify the idea that impaired synaptogenesis underlies the pathogenesis of ASD, we examined the relationship between mutations in the CADM1 gene and ASD. We found two missense Mutations, C739A(H246N) and A755C(Y251S), in the CADM1 gene of male Caucasian ASD patients and their family members. Both mutations were located in the third immunoglobulin domain, which is essential for trans-active interaction. The mutated CADM1 exhibited less amount of high molecular weight with the Matured oligosaccharide, defective trafficking to the cell surface, and more susceptibility to the cleavage and or degradation. Our findings provide key support for the unified idea that impaired synaptogenesis underlies the pathogenesis of ASD. (C) 2008 Published by Elsevier Inc.
引用
收藏
页码:926 / 929
页数:4
相关论文
共 50 条
  • [41] The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
    Lafage-Pochitaloff, Marina
    Gerby, Bastien
    Baccini, Veronique
    Largeaud, Laetitia
    Fregona, Vincent
    Prade, Nais
    Juvin, Pierre-Yves
    Jamrog, Laura
    Bories, Pierre
    Hebrard, Sylvie
    Lagarde, Stephanie
    Mansat-De Mas, Veronique
    Dovey, Oliver M.
    Yusa, Kosuke
    Vassiliou, George S.
    Jansen, Joop H.
    Tekath, Tobias
    Rombaut, David
    Ameye, Genevieve
    Barin, Carole
    Bidet, Audrey
    Boudjarane, John
    Collonge-Rame, Marie-Agnes
    Gervais, Carine
    Ittel, Antoine
    Lefebvre, Christine
    Luquet, Isabelle
    Michaux, Lucienne
    Nadal, Nathalie
    Poirel, Helene A.
    Radford-Weiss, Isabelle
    Ribourtout, Benedicte
    Richebourg, Steven
    Struski, Stephanie
    Terre, Christine
    Tigaud, Isabelle
    Penther, Dominique
    Eclache, Virginie
    Fontenay, Michaela
    Broccardo, Cyril
    Delabesse, Eric
    BLOOD ADVANCES, 2022, 6 (02) : 386 - 398
  • [42] Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia
    Phillips, Samuel
    Cassells, Kahli
    Garland, Suzanne M.
    Machalek, Dorothy A.
    Roberts, Jennifer M.
    Templeton, David J.
    Jin, Fengyi
    Poynten, I. Mary
    Hillman, Richard J.
    Grulich, Andrew E.
    Murray, Gerald L.
    Tabrizi, Sepehr N.
    Molano, Monica
    Cornall, Alyssa M.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [43] Differential Expression of CADM1 in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities
    Yuan, Jiayin
    Kihara, Takako
    Kimura, Neinei
    Hashikura, Yuka
    Ohkouchi, Mizuka
    Isozaki, Koji
    Takahashi, Tsuyoshi
    Nishida, Toshirou
    Ito, Akihiko
    Hirota, Seiichi
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [44] Functional Characterization of Ankyrin Loss-Of-Function Mutations Associated With Autism Spectrum Disorder
    Garza, Jacob
    Petryshen, Tracey
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S552 - S553
  • [45] A Review on the Role of Genetic Mutations in the Autism Spectrum Disorder
    Ghafouri-Fard, Soudeh
    Pourtavakoli, Ashkan
    Hussen, Bashdar Mahmud
    Taheri, Mohammad
    Ayatollahi, Seyed Abdulmajid
    MOLECULAR NEUROBIOLOGY, 2023, 60 (09) : 5256 - 5272
  • [46] A Review on the Role of Genetic Mutations in the Autism Spectrum Disorder
    Soudeh Ghafouri-Fard
    Ashkan Pourtavakoli
    Bashdar Mahmud Hussen
    Mohammad Taheri
    Seyed Abdulmajid Ayatollahi
    Molecular Neurobiology, 2023, 60 : 5256 - 5272
  • [47] Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
    Wikman, Harriet
    Westphal, Laura
    Schmid, Felicitas
    Pollari, Sirkku
    Kropidlowski, Jolanthe
    Sielaff-Frimpong, Bettina
    Glatzel, Markus
    Matschke, Jakob
    Westphal, Manfred
    Iljin, Kristiina
    Huhtala, Heini
    Terracciano, Luigi
    Kallioniemi, Anne
    Sauter, Guido
    Mueller, Volkmar
    Witzel, Isabell
    Lamszus, Katrin
    Kemming, Dirk
    Pantel, Klaus
    ONCOTARGET, 2014, 5 (10) : 3076 - 3087
  • [48] Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia
    Samuel Phillips
    Kahli Cassells
    Suzanne M. Garland
    Dorothy A. Machalek
    Jennifer M. Roberts
    David J. Templeton
    Fengyi Jin
    I. Mary Poynten
    Richard J. Hillman
    Andrew E. Grulich
    Gerald L. Murray
    Sepehr N. Tabrizi
    Monica Molano
    Alyssa M. Cornall
    Scientific Reports, 12
  • [49] The rs594445 in MOCOS gene is associated with risk of autism spectrum disorder
    Mohammad Taheri
    Rezvan Noroozi
    Kamyar Aghaei
    Mir Davood Omrani
    Soudeh Ghafouri-Fard
    Metabolic Brain Disease, 2020, 35 : 497 - 501
  • [50] PATERNAL ORIGIN DOPA DECARBOXYLASE GENE VARIANTS ARE ASSOCIATED WITH AUTISM SPECTRUM DISORDER
    Hansen, Christine
    Starnawska, Anna
    Bybjerg-Grauholm, Jonas
    Lindgren, Cecilia
    Werge, Thomas
    Buil, Alfonso
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S123 - S124